| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1468-1331.2012.03693.X |
| P698 | PubMed publication ID | 22435925 |
| P50 | author | Franz Fazekas | Q43184302 |
| P2093 | author name string | R Schmidt | |
| R Möller | |||
| S Weiss | |||
| C Bernecker | |||
| C Ragginer | |||
| H-J Gruber | |||
| M Truschnig-Wilders | |||
| A Lechner | |||
| M Wallner-Blazek | |||
| R Horejsi | |||
| P2860 | cites work | Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation | Q58874465 |
| Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow | Q30914751 | ||
| Association between plasma lipid levels and migraine in subjects aged > or =50 years: preliminary data from the Zabùt Aging Project | Q31158808 | ||
| Glutamate transporters in neurologic disease | Q34187611 | ||
| Glutamate transporters: animal models to neurologic disease | Q35729357 | ||
| Obesity and migraine: the effect of age, gender and adipose tissue distribution. | Q36592807 | ||
| Migraine: gene mutations and functional consequences | Q36818663 | ||
| The role of glutamate and its receptors in migraine | Q36907398 | ||
| The brain is hyperexcitable in migraine | Q37012139 | ||
| Migraine and obesity: epidemiology, mechanisms, and implications | Q37618928 | ||
| Glutamatergic fine tuning with ADX-10059: a novel therapeutic approach for migraine? | Q37706619 | ||
| Substrate-induced modulation of glutamate uptake in human platelets | Q42125336 | ||
| Lipid profile in normal weight migraineurs - evidence for cardiovascular risk | Q43227931 | ||
| Hyperinsulinaemia in migraineurs is associated with nitric oxide stress | Q43279152 | ||
| Cerebrospinal fluid glutamate levels in chronic migraine | Q45021407 | ||
| Cardiovascular risk factors and migraine: the GEM population-based study | Q45280632 | ||
| Effective prophylactic treatments of migraine lower plasma glutamate levels | Q46146404 | ||
| Platelet membrane fluidity and peroxynitrite levels in migraine patients during headache-free periods. | Q46445172 | ||
| Insulin sensitivity is impaired in patients with migraine | Q46610301 | ||
| Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? | Q46871325 | ||
| Migraine and biomarkers of cardiovascular disease in women. | Q46912160 | ||
| Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine. | Q48131922 | ||
| Platelet glutamate uptake and release in migraine with and without aura | Q48315315 | ||
| Neurochemistry of trigeminal activation in an animal model of migraine. | Q48439405 | ||
| In search of the ideal treatment for migraine headache | Q48728838 | ||
| The effects of estrogen and progesterone on blood glutamate levels: evidence from changes of blood glutamate levels during the menstrual cycle in women. | Q51535524 | ||
| P433 | issue | 8 | |
| P921 | main subject | migraine | Q133823 |
| P304 | page(s) | 1146-1150 | |
| P577 | publication date | 2012-03-21 | |
| P1433 | published in | European Journal of Neurology | Q15757256 |
| P1476 | title | Reduced urinary glutamate levels are associated with the frequency of migraine attacks in females. | |
| P478 | volume | 19 |
| Q36303842 | Enhanced Performance of Colorimetric Biosensing on Paper Microfluidic Platforms Through Chemical Modification and Incorporation of Nanoparticles. |
| Q43358780 | Glutamate oxaloacetate transaminase: a new key in the dysregulation of glutamate in migraine patients |
| Q36441644 | Mass spectrometry imaging of amino neurotransmitters: a comparison of derivatization methods and application in mouse brain tissue. |
| Q28395080 | Modification of microfluidic paper-based devices with silica nanoparticles |
| Q46040914 | Progress in European neurology 2012-2013. |
| Q47160004 | Re‐evaluation of glutamic acid (E 620), sodium glutamate (E 621), potassium glutamate (E 622), calcium glutamate (E 623), ammonium glutamate (E 624) and magnesium glutamate (E 625) as food additives |
Search more.